Non-ownership Filings
| Initiation of Toxicology Studies for SDC-1801 | May. 29, 2025 |
| Update on TYK2/JAK1 and SRA737 Programmes | Apr. 28, 2025 |
| Exercise of Warrants | Apr. 24, 2025 |
| Sareum Half-Year Report | Mar. 25, 2025 |
| Notice of HY Results and Investor Presentation | Mar. 20, 2025 |
| Institutional Equity Fundraise | Mar. 13, 2025 |
| Sareum Acquires Licence for SRA737 | Mar. 13, 2025 |
Ownership Update Filings
| Director’s Dealing | Mar. 27, 2025 |
| Completion of Equity Fundraise | Apr. 04, 2024 |
| Director Dealings | Nov. 08, 2023 |
| Exercise of Share Options and Director Dealings | Nov. 02, 2023 |
| Director's Dealing | Sep. 06, 2023 |
| Director Dealing | Sep. 05, 2023 |
| Director/PDMR Shareholding | Nov. 23, 2021 |